Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry.

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/38741480

Antje Dickmanns; Godefridus J Peters; Kim M Stegmann; Krzysztof Urbanowicz; Matthias Dobbelstein; Mikolaj Opielka

May 14, 2024